London (AFP) - An Ebola vaccine by British pharmaceuticals giant GlaxoSmithKline may not be ready for commercial use until late 2016 and should therefore not be seen as the "primary answer" to the current outbreak, a company researcher said.
via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment